All News
Can Rituximab Change the Course of Interstitial Lung Disease?
Like other extraarticular manifestations, rheumatoid (RA) or connective tissue disease (CTD) related interstitial lung disease (ILD) is difficult to identify early and equally challenging to treat.
Read Article
Posterior Reversible Encephalopathy in Lupus
Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder with many associations or causative factors that rarely includes autoimmune disorders and lupus.
Read Article
CV Events Strike Early in Lupus
Patients with systemic lupus erythematosus are at risk of cardiovascular events early in the course of disease -- and even before their lupus is diagnosed, an international study found.
Read ArticleRheumNow Week in Review - 15 April 2016
Video recap of highlights from this week at RheumNow.com.
Read ArticleBiosimilar Reports - April 2016
Major advances in biosimilars have occurred in the last three months, beginning with the FDA Arthritis Advisory Committee voting 21-3 to approve Celltrion’s Inflectra (CT-P13) and ending with the recent approval of Inflectra (generically referred to as infliximab dyyb).
Read ArticleLupus Patients Genomically Stratified to Explain Treatment Responses
Systemic lupus is a clinically heterogeneous disorder, unified by requisite clinical features and exuberant humoral response to unknown triggers. While the diagnosis is easy, the disease course and management can be complicated and challenging.
Read ArticleRheumNow Week in Review - 8 April 2016
Dr. Jack Cush reviews the rheumatology highlights from the news, media, and journals from this past week:
Read ArticleAltering the Microbiome May Benefit Lupus Patients
Lopez and colleagues from Spain have studied the gut microbiome of l
Read ArticleChoosing ANA Tests Wisely - Education Fosters Smarter Use
It is estimated that 21% of laboratory tests are requested inappropriately. Researchers have explored the impact of educational programs for rheumatologists working at three rheumatology departments in secondary and tertiary care centers in The Netherlands.
Read ArticleEUSTAR Analysis Yields Predictors of Skin Improvement in Diffuse Systemic Sclerosis
Systemic sclerosis is one of the most challenging of rheumatic diseases, often complicated by significant morbidity and leads to irreversible disability in many cases.
Read ArticleDr. Evelyn Hess (1925-2015) - Working With and For the Patient
RheumNow sadly notes that rheumatology icon and educator Dr. Evelyn Hess passed away on December 25, 2015. She leaves behind a legacy career and a legion of clinicians, teachers, researchers and leaders whom she taught and inspired.
Read ArticleThe Week in Review 18 March 2016
See the highlights from the past week that appeared on RheumNow.com, and watch Dr. Jack Cush as he reviews each of them.
Read ArticleJanuary/February 2016 Top Social Media News
In February 2016, RheumNow published 82 tweets about impactful news, research and teaching points that impact the rheumatology community. These feeds had a reach (impressions) of 80,800 with, 76 mentions, and over 2700 visits to learn on RheumNow.com.
Read ArticleRisk Factors for Pulmonary Hypertension in Lupus
Fidler and colleagues from Toronto have recently shown that pulmonary disease is common in lupus, as they found 56% of their patients with abnormal pulmonary assessments.
Read ArticleACR Invites Comment on Perioperative Management Guidelines
The ACR is inviting members and rheumatologists to comment on their proposal to develop recommendations for the "Perioperative Management of Rheumatic Disease Medications in Total Joint Arthroplasty of the Hip and Knee".
Read ArticleCombined Dermatology-Rheumatology Clinics Benefits Patients
Healio reports that patients followed in a combined Dermatology and Rheumatology clinic in Canada revealed high patient satisfaction.
Read ArticleTocilizumab Induces and Maintains Remission in Giant Cell Arteritis
Lancet has reported the results of a randomized, double-blind, placebo-controlled trial of tocilizumab in patients with new-onset giant cell arteritis (GCA).
Read Article"Lost to Follow-up" Patients are Common in Rheumatology
The frequency of not returning (lost to follow-up) (LTFU) in patients with rheumatic diseases is high. Associated demographic factors included older age in RA, female gender in SLE and Ps/PsA, and younger age in Ps/PsA, with various reasons for being LTFU.
Read Article